Sea Limited's consensus analyst price target has seen a slight uptick, moving from $204.35 to $204.64. This modest revision reflects growing optimism from bullish analysts who point to strengthening ...
SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, today announced positive topline results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback